Approval · Notice of Compliance 2333 · 2001
FERRLECIT: Notice of Compliance 2333
Issued July 25, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2333
- Date
- July 25, 2001
- Company
- Watson Laboratories IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- New manufacturer name
- Therapeutic class
- Hematinic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FERRLECIT | 02243333 | Marketed |
Medicinal ingredients
- SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE INJECTION 12.5 MG per ML